Percutaneous cementoplasty for acetabulum in patients with bone metastasis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Eun-Seok | - |
dc.contributor.author | Kim, Yong-il | - |
dc.contributor.author | Kang, Hyun Guy | - |
dc.contributor.author | Kim, June Hyuk | - |
dc.contributor.author | Kim, Han Soo | - |
dc.contributor.author | Lin, Patrick P. | - |
dc.date.available | 2020-02-27T23:42:50Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 0001-6462 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/7559 | - |
dc.description.abstract | The purpose of this study is to demonstrate the surgical technique and to show the results of percutaneous cementoplasty (PC) for acetabular metastases using lateral approach under regional anesthesia. Forty-two cases underwent PC for acetabular metastases. The PC was performed using spinal anesthesia, lateral approach and fluoroscopic guidance. We assessed visual analogue scale (VAS) and revised musculoskeletal tumor society (MSTS) rating system and maximum standardized uptake value (SUVmax) of the acetabular lesion using F-18-FDG PET/CT before and after the PC. The mean injected volume of polymethylmethacrylamide to the pelvis was 21 +/- 11.8 ml. The mean of regional VAS (6.2 +/- 1.1 vs. 3.1 +/- 2.7, p< 0.001), MSTS (10.3 +/- 3.9 vs. 18.3 +/- 3.2, p< 0.001) and local SUVmax (8.6 +/- 5.2 vs. 5.7 +/- 3.6, p = 0.012) on PET/CT showed significant reductions after surgery. Twenty-three patients (55%) died of disease at mean 11.8 +/- 4.8 months after surgery. PC using lateral approach and regional anesthesia could be a simple and safe surgical method for relieving pain and maintaining skeletal stability against acetabular metastasis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ACTA MEDICA BELGICA | - |
dc.relation.isPartOf | ACTA ORTHOPAEDICA BELGICA | - |
dc.subject | RADIATION-THERAPY | - |
dc.subject | RANDOMIZED-TRIAL | - |
dc.subject | PAIN RELIEF | - |
dc.subject | CEMENT | - |
dc.subject | RECONSTRUCTION | - |
dc.subject | RADIOTHERAPY | - |
dc.subject | MANAGEMENT | - |
dc.subject | QUALITY | - |
dc.subject | LIFE | - |
dc.title | Percutaneous cementoplasty for acetabulum in patients with bone metastasis | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000429033000018 | - |
dc.identifier.bibliographicCitation | ACTA ORTHOPAEDICA BELGICA, v.83, no.3, pp.480 - 487 | - |
dc.identifier.scopusid | 2-s2.0-85042716099 | - |
dc.citation.endPage | 487 | - |
dc.citation.startPage | 480 | - |
dc.citation.title | ACTA ORTHOPAEDICA BELGICA | - |
dc.citation.volume | 83 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Choi, Eun-Seok | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Percutaneous Cementoplasty | - |
dc.subject.keywordAuthor | Acetabulum | - |
dc.subject.keywordAuthor | Metastasis | - |
dc.subject.keywordAuthor | F-18-FDGPET/CT | - |
dc.subject.keywordPlus | RADIATION-THERAPY | - |
dc.subject.keywordPlus | RANDOMIZED-TRIAL | - |
dc.subject.keywordPlus | PAIN RELIEF | - |
dc.subject.keywordPlus | CEMENT | - |
dc.subject.keywordPlus | RECONSTRUCTION | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | QUALITY | - |
dc.subject.keywordPlus | LIFE | - |
dc.relation.journalResearchArea | Orthopedics | - |
dc.relation.journalWebOfScienceCategory | Orthopedics | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.